---
title: "Neurocrine Is Maintained at Buy by Canaccord Genuity"
date: "2025-02-08 03:06:00"
summary: "(19:06 GMT) Neurocrine Price Target Cut to $163.00/Share From $172.00 by Canaccord Genuity"
categories:
  - "Dow Jones Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Dow Jones Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

**(19:06 GMT)** Neurocrine Price Target Cut to $163.00/Share From $172.00 by Canaccord Genuity

[Dow Jones Newswires](https://www.tradingview.com/news/DJN_DN20250207009189:0/)
